{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:02:27Z","timestamp":1790182947187,"version":"4.1.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013126","name":"Psoriasis Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013126","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["206194"],"award-info":[{"award-number":["206194"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["108413\/A\/15\/D"],"award-info":[{"award-number":["108413\/A\/15\/D"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007155","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007155","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Research Council Clinical Academic Research Partnership"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Ultraviolet radiation (UVR) is used as treatment for psoriasis and other skin diseases, but UVR can induce DNA mutations that may lead to skin cancer development. While skin cancers have been documented in patients treated with phototherapy, a limited number of epidemiological studies have examined the incidence of skin cancer in people receiving narrowband ultraviolet B (NB-UVB) treatment. Information on the mutagenicity of NB-UVB would help inform about the potential skin cancer risks of this treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To determine the mutation burden in human skin resulting from a NB-UVB treatment course and to use this data to estimate the total number of NB-UVB exposures whereupon skin cancer surveillance should begin.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Biopsies of normal skin were obtained before and after a course of NB-UVB from 16 patients with psoriasis. Epidermal DNA was sequenced using nanorate sequencing (NanoSeq) to determine the mutational signatures and mutation burden from NB-UVB.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The NB-UVB treatment course increased the number of mutations in skin. Median increase in mutation burden was 0.55 substitutions per Mb in infrequently sun-exposed (buttock; n = 14) skin and 0.89 substitutions per Mb in frequently sun-exposed (forearm; n = 10) skin (P &amp;lt; 0.001). Change in mutation burden due to NB-UVB ranged from 1.16- to 10.50-fold in buttock skin and from 0.93- to 2.33-fold in forearm skin. This increase was mainly attributable to UVR exposure-linked mutational signatures, SBS7a and SBS7b, with some evidence that mutational burden was related to the genetic background of the individual. Modelling the change in mutation burden from NB-UVB relative to minimal erythema dose (MED) in comparison with average mutation burden in keratinocyte skin cancers allowed estimation of total lifetime exposures at which patients are likely to require skin cancer surveillance; for patients with a MED equal to 2 standard erythemal doses (SEDs), skin cancer surveillance should be offered at 422, 165 and 58 NB-UVB exposures for those receiving low, typical and high levels of sun exposure, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>A treatment course of NB-UVB causes UVR-induced mutations in the healthy skin of patients with psoriasis. Relating mutation burden to MED and sun behaviour habits allows estimation of when to begin skin cancer surveillance according to total lifetime NB-UVB exposures.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bjd\/ljaf173","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T08:59:49Z","timestamp":1746176389000},"page":"718-728","source":"Crossref","is-referenced-by-count":2,"title":["Mutation burden of narrowband ultraviolet B phototherapy (NB-UVB) in human skin: relevance to NB-UVB lifetime exposures and skin cancer surveillance"],"prefix":"10.1093","volume":"193","author":[{"given":"Joanna C","family":"Fowler","sequence":"first","affiliation":[{"name":"Wellcome Sanger Institute , Wellcome Genome Campus, Hinxton, Cambridge ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshan K","family":"Sood","sequence":"additional","affiliation":[{"name":"Wellcome Sanger Institute , Wellcome Genome Campus, Hinxton, Cambridge ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7648-8741","authenticated-orcid":false,"given":"George","family":"Coltart","sequence":"additional","affiliation":[{"name":"Dermatopharmacology, University of Southampton, Southampton General Hospital , Southampton ,","place":["UK"]},{"name":"Dermatology, University Hospital Southampton NHS Foundation Trust , Southampton ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2282-5655","authenticated-orcid":false,"given":"Chester","family":"Lai","sequence":"additional","affiliation":[{"name":"Dermatopharmacology, University of Southampton, Southampton General Hospital , Southampton ,","place":["UK"]},{"name":"Dermatology, University Hospital Southampton NHS Foundation Trust , Southampton ,","place":["UK"]},{"name":"Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong , Hong Kong SAR ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noeline","family":"Nadarajah","sequence":"additional","affiliation":[{"name":"Dermatopharmacology, University of Southampton, Southampton General Hospital , Southampton ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9998-0464","authenticated-orcid":false,"given":"John W","family":"Holloway","sequence":"additional","affiliation":[{"name":"Human Development and Health, University of Southampton, Southampton General Hospital , Southampton ,","place":["UK"]},{"name":"Institute for Life Sciences, University of Southampton , Southampton ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1064-5350","authenticated-orcid":false,"given":"Matthew J J","family":"Rose-Zerilli","sequence":"additional","affiliation":[{"name":"Institute for Life Sciences, University of Southampton , Southampton ,","place":["UK"]},{"name":"Cancer Sciences, University of Southampton, Southampton General Hospital , Southampton ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8955-125X","authenticated-orcid":false,"given":"Brian","family":"Diffey","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute (Dermatology), Newcastle University , Newcastle upon Tyne ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5904-795X","authenticated-orcid":false,"given":"Philip H","family":"Jones","sequence":"additional","affiliation":[{"name":"Wellcome Sanger Institute , Wellcome Genome Campus, Hinxton, Cambridge ,","place":["UK"]},{"name":"Department of Oncology, University of Cambridge , Hutchison Research Centre, Cambridge ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5591-6970","authenticated-orcid":false,"given":"Eugene","family":"Healy","sequence":"additional","affiliation":[{"name":"Dermatopharmacology, University of Southampton, Southampton General Hospital , Southampton ,","place":["UK"]},{"name":"Dermatology, University Hospital Southampton NHS Foundation Trust , Southampton ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,3]]},"reference":[{"key":"2025091919453077200_ljaf173-B1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/php.12377","article-title":"UV signature mutations","volume":"91","author":"Brash","year":"2015","journal-title":"Photochem Photobiol"},{"key":"2025091919453077200_ljaf173-B2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMra1708701","article-title":"Update on keratinocyte carcinomas","volume":"379","author":"Nehal","year":"2018","journal-title":"N Engl J Med"},{"key":"2025091919453077200_ljaf173-B3","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jaad.2019.04.042","article-title":"Joint American Academy of Dermatology\u2013National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy","volume":"81","author":"Elmets","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2025091919453077200_ljaf173-B4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/bjd.21669","article-title":"British Association of Dermatologists and British Photodermatology Group guidelines for narrowband ultraviolet B phototherapy 2022","volume":"187","author":"Goulden","year":"2022","journal-title":"Br J Dermatol"},{"key":"2025091919453077200_ljaf173-B5","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1016\/j.jaad.2020.02.051","article-title":"Why can we see our narrowband UVB lights?","volume":"82","author":"Soleymani","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2025091919453077200_ljaf173-B6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1600-0781.2003.00063.x","article-title":"Effect of the spectral range of a UV lamp on the production of cyclobutane pyrimidine dimers in human skin in situ","volume":"19","author":"Snellman","year":"2003","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"2025091919453077200_ljaf173-B7","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/php.13568","article-title":"Cyclobutane pyrimidine dimers produced with narrowband UVB are on average more mutagenic than those with broadband UVB in mouse skin","volume":"98","author":"Ikehata","year":"2022","journal-title":"Photochem Photobiol"},{"key":"2025091919453077200_ljaf173-B8","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1038\/sj.jid.5701001","article-title":"Narrow-band UVB induces more carcinogenic skin tumors than broad-band UVB through the formation of cyclobutane pyrimidine dimer","volume":"127","author":"Kunisada","year":"2007","journal-title":"J Invest Dermatol"},{"key":"2025091919453077200_ljaf173-B9","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1365-2133.2008.08776.x","article-title":"Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy","volume":"159","author":"Hearn","year":"2008","journal-title":"Br J Dermatol"},{"issue":"Suppl. 3","key":"2025091919453077200_ljaf173-B10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1468-3083.2012.04520.x","article-title":"Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review","volume":"26","author":"Archier","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025091919453077200_ljaf173-B11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/phpp.12443","article-title":"Risk of skin cancer in psoriasis patients receiving long-term narrowband ultraviolet phototherapy: results from a Taiwanese population-based cohort study","volume":"35","author":"Lin","year":"2019","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"2025091919453077200_ljaf173-B12","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v104.39927","article-title":"Skin cancer risk of narrow-band UV-B (TL-01) phototherapy: a multi-center registry study with 4815 patients","volume":"104","author":"Akerla","year":"2024","journal-title":"Acta Derm Venereol"},{"key":"2025091919453077200_ljaf173-B13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/jamadermatol.2020.0218","article-title":"Evaluation for skin cancer and precancer in patients with vitiligo treated with long-term narrowband UV-B phototherapy","volume":"156","author":"Bae","year":"2020","journal-title":"JAMA Dermatol"},{"key":"2025091919453077200_ljaf173-B14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1158\/2159-8290.CD-20-1092","article-title":"Selection of oncogenic mutant clones in normal human skin varies with body site","volume":"11","author":"Fowler","year":"2021","journal-title":"Cancer Discov"},{"key":"2025091919453077200_ljaf173-B15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ng.3525","article-title":"Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma","volume":"48","author":"Bonilla","year":"2016","journal-title":"Nat Genet"},{"key":"2025091919453077200_ljaf173-B16","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1038\/s41467-018-06027-1","article-title":"The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature","volume":"9","author":"Inman","year":"2018","journal-title":"Nat Commun"},{"key":"2025091919453077200_ljaf173-B17","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1126\/science.aaa6806","article-title":"Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin","volume":"348","author":"Martincorena","year":"2015","journal-title":"Science"},{"key":"2025091919453077200_ljaf173-B18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jid.2017.07.844","article-title":"Subclonal evolution of cancer-related gene mutations in p53 immunopositive patches in human skin","volume":"138","author":"Albibas","year":"2018","journal-title":"J Invest Dermatol"},{"key":"2025091919453077200_ljaf173-B19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-021-03477-4","article-title":"Somatic mutation landscapes at single-molecule resolution","volume":"593","author":"Abascal","year":"2021","journal-title":"Nature"},{"key":"2025091919453077200_ljaf173-B20","author":"Commission Internationale de l'\u00c9clairage","year":"2006"},{"key":"2025091919453077200_ljaf173-B21","author":"Commission Internationale de l\u2019Eclairage","year":"1998"},{"key":"2025091919453077200_ljaf173-B22","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature"},{"key":"2025091919453077200_ljaf173-B23","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archderm.1988.01670060031011","article-title":"Unreliability of self-reported burning tendency and tanning ability","volume":"124","author":"Rampen","year":"1988","journal-title":"Arch Dermatol"},{"key":"2025091919453077200_ljaf173-B24","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jamadermatol.2013.6101","article-title":"Accuracy of self-report in assessing Fitzpatrick skin phototypes I through VI","volume":"149","author":"Eilers","year":"2013","journal-title":"JAMA Dermatol"},{"key":"2025091919453077200_ljaf173-B25","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41588-021-00783-5","article-title":"The Polygenic Score Catalog as an open database for reproducibility and systematic evaluation","volume":"53","author":"Lambert","year":"2021","journal-title":"Nat Genet"},{"key":"2025091919453077200_ljaf173-B26","doi-asserted-by":"crossref","first-page":"11466","DOI":"10.1016\/S0021-9258(18)37980-8","article-title":"DNA sequence specificity of 4,5\u2019,8-trimethylpsoralen cross-linking. Effect of neighboring bases on cross-linking the 5'-TA dinucleotide","volume":"263","author":"Esposito","year":"1988","journal-title":"J Biol Chem"},{"key":"2025091919453077200_ljaf173-B27","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.0022-202X.2004.23502.x","article-title":"Biological consequences of 8-methoxypsoralen-photoinduced lesions: sequence-specificity of mutations and preponderance of T to C and T to A mutations","volume":"123","author":"Besaratinia","year":"2004","journal-title":"J Invest Dermatol"},{"key":"2025091919453077200_ljaf173-B28","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1038\/s41588-023-01545-1","article-title":"Effects of psoriasis and psoralen exposure on the somatic mutation landscape of the skin","volume":"55","author":"Olafsson","year":"2023","journal-title":"Nat Genet"},{"key":"2025091919453077200_ljaf173-B29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/285407a0","article-title":"5-Methoxypsoralen, an ingredient in several suntan preparations, has lethal, mutagenic and clastogenic properties","volume":"285","author":"Ashwood-Smith","year":"1980","journal-title":"Nature"},{"key":"2025091919453077200_ljaf173-B30","doi-asserted-by":"crossref","DOI":"10.1088\/978-0-7503-1377-3","volume-title":"Sun Protection: A Risk Management Approach","author":"Diffey","year":"2017"},{"key":"2025091919453077200_ljaf173-B31","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/php.13846","article-title":"Is sunscreen alone effective at preventing sunburn on a high-solar beach vacation: a modelling study?","volume":"100","author":"Diffey","year":"2024","journal-title":"Photochem Photobiol"},{"key":"2025091919453077200_ljaf173-B32","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/bjd.17277","article-title":"Sunscreen applied at \u22652\u2005mg cm\u22122 during a sunny holiday prevents erythema, a \u00adbiomarker of ultraviolet radiation-induced DNA damage and \u00adsuppression of acquired immunity","volume":"180","author":"Narbutt","year":"2019","journal-title":"Br J Dermatol"},{"key":"2025091919453077200_ljaf173-B33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1011-1344(01)00198-1","article-title":"The epidemiology of UV induced skin cancer","volume":"63","author":"Armstrong","year":"2001","journal-title":"J Photochem Photobiol B"},{"key":"2025091919453077200_ljaf173-B34","first-page":"893","article-title":"Prediction of skin cancer occurrence by ultraviolet solar index","volume":"3","author":"Rivas","year":"2012","journal-title":"Oncol Lett"},{"key":"2025091919453077200_ljaf173-B35","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1046\/j.1365-2133.2003.05447.x","article-title":"Factors affecting the choice of a ceiling on the number of exposures with TL01 ultraviolet B phototherapy","volume":"149","author":"Diffey","year":"2003","journal-title":"Br J Dermatol"},{"key":"2025091919453077200_ljaf173-B36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1046-2023(02)00205-0","article-title":"Ultraviolet radiation-induced erythema in human skin","volume":"28","author":"Harrison","year":"2002","journal-title":"Methods"},{"key":"2025091919453077200_ljaf173-B37","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/s41588-023-01468-x","article-title":"Somatic mutations in facial skin from countries of contrasting skin cancer risk","volume":"55","author":"King","year":"2023","journal-title":"Nat Genet"},{"key":"2025091919453077200_ljaf173-B38","doi-asserted-by":"crossref","first-page":"e1010105","DOI":"10.1371\/journal.pgen.1010105","article-title":"Significant sparse polygenic risk scores across 813 traits in UK Biobank","volume":"18","author":"Tanigawa","year":"2022","journal-title":"PLOS Genet"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljaf173\/63049921\/ljaf173.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/193\/4\/718\/63049921\/ljaf173.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/193\/4\/718\/63049921\/ljaf173.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T23:45:44Z","timestamp":1758325544000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/193\/4\/718\/8124470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,3]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,5,3]]},"published-print":{"date-parts":[[2025,9,18]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljaf173","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,5,3]]}}}